Ascendis Pharma A/S Forecast and Stock Analysis
Technical ASND stock analysis for Wednesday June 19, 2019.
Ascendis Pharma A/S gained 0.37% in the last trading day ( Wednesday, 19th Jun 2019 ), rising from $125.69 to $126.15 During day the stock fluctuated 2.66% from a day low at $123.72 to a day high of $127.02. The price has been going up and down for this period, and there has been a -0.86% loss for the last 2 weeks. Volume fell in the last day by -232 651 shares, and in total, 316 531 shares bought and sold for approximately $39.93 million. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.
- 30 day high of the ASND stock price was $133.96 and low was $115.80.
- 90 day high was $133.96 and low was $105.02.
- 52 week high for the Ascendis Pharma A/S - $133.96 and low - $53.21.
Ascendis Pharma A/S lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 10.04% during the next 3 months and, with 90% probability hold a price between $127.07 and $147.92 at the end of this period.
Only positive signals in the chart today. Ascendis Pharma A/S holds buy signals from both short- and long-term moving averages, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down there will be some support from the lines at $123.18 and $123.86. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday June 18, 2019, which indicates further gains until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and may be an early warning. The stock should be watched closely.
Relative Strength Index (RSI)
RSI14 is 47 and the stock is currently not being overbought or oversold
Support & Resistance
Ascendis Pharma A/S finds support from accumulated volume at $125.69.
This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved $3.30 (2.66%) between high and low. For the last week, the stock has had a daily average volatility of 3.74%.
Our recommended stoploss: $118.90 (-5.75%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 1 days ago.)
3.74 %Average volatility
Very Low Low Medium High Very High
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term. We have upgraded our recommendation for this stock since last evaluation from a Sell Candidate to a Buy Candidate.
|Golden Star Signal|
Get competitive edge
The signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives a very good return. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!
Get access to Golden Star list now
|ASND $126.15 ($0.46 0.37%)|
ASND is up $0.46 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for ASND based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the ASND analysis is free »
From Our Blog
- Trading With Moving Average
- Pivot Points
- Accumulated Volume - Support and Resistance
- Volume - The Indicator You Really Need to Know
- We Give Back!
- Better Buy: Amazon vs. Facebook
- Better Buy: Apple vs. Microsoft
- Relative Strength Index (RSI)
- How to Lose Money When Trading: Part 2
- How to Lose Money When Trading: A Trader is Born
- Our 2017 Christmas Donation
- The Golden Star
- Announcing Partnership With CityFALCON
- Why correct moving average matters
- NASDAQ down -4.17%. Our portfolio is up +8.56%
- New Feature Added: Golden Star Signal
- Pick a Winner With StockInvest.us